Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients (STELLAR)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02796261 |
|
Recruitment Status :
Active, not recruiting
First Posted : June 10, 2016
Last Update Posted : January 21, 2022
|
Sponsor:
Orbus Therapeutics, Inc.
Information provided by (Responsible Party):
Orbus Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2023 |
| Estimated Study Completion Date : | June 2023 |